NeoVanc: Treatment of late onset bacterial sepsis caused by Vancomycin susceptible bacteria in neonates and infants aged under three months (RTD Budget)

  • Ghazal, Peter (Principal Investigator)

Project Details

StatusFinished
Effective start/end date1/02/14 → 31/01/19

Funding

  • EU government bodies: £125,504.00
  • EU government bodies: £1,835.00